Sanofi, Sobi''s hemophilia A therapy gets FDA priority review
The U.S. Food and Drug Administration (FDA) granted priority review to Sanofi (SNY) and Swedish Orphan Biovitrum''s (Sobi) efanesoctocog alfa (BIVV001) to treat people with hemophilia…
Sanofi, Sobi''s hemophilia A therapy gets FDA priority review
The U.S. Food and Drug Administration (FDA) granted priority review to Sanofi (SNY) and Swedish Orphan Biovitrum''s (Sobi) efanesoctocog alfa (BIVV001) to treat people with hemophilia…